216 related articles for article (PubMed ID: 16429427)
1. Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children.
Pajaron-Fernandez M; Garcia-Rubia S; Sanchez-Solis M; Garcia-Marcos L
Pediatr Pulmonol; 2006 Mar; 41(3):222-7. PubMed ID: 16429427
[TBL] [Abstract][Full Text] [Related]
2. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
Philip G; Villarán C; Pearlman DS; Loeys T; Dass SB; Reiss TF
J Asthma; 2007 Apr; 44(3):213-7. PubMed ID: 17454341
[TBL] [Abstract][Full Text] [Related]
3. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
4. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
[TBL] [Abstract][Full Text] [Related]
5. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].
Sun TY; Guo YF; Xu XM; Zhang HS; Hou J; Ke HX; Li YM; Fang BM; Ming SH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387
[TBL] [Abstract][Full Text] [Related]
6. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
[TBL] [Abstract][Full Text] [Related]
7. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
[TBL] [Abstract][Full Text] [Related]
8. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
[TBL] [Abstract][Full Text] [Related]
9. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
Fogel RB; Rosario N; Aristizabal G; Loeys T; Noonan G; Gaile S; Smugar SS; Polos PG
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
11. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.
Rundell KW; Spiering BA; Baumann JM; Evans TM
Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction.
Kang MJ; Lee SY; Kim HB; Yu J; Kim BJ; Choi WA; Jang SO; Hong SJ
Pharmacogenet Genomics; 2008 Jul; 18(7):551-8. PubMed ID: 18551035
[TBL] [Abstract][Full Text] [Related]
13. Time-effect of montelukast on protection against exercise-induced bronchoconstriction.
Peroni DG; Pescollderungg L; Sandri M; Chinellato I; Boner AL; Piacentini GL
Respir Med; 2011 Dec; 105(12):1790-7. PubMed ID: 21865022
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
Raissy HH; Harkins M; Kelly F; Kelly HW
Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
[TBL] [Abstract][Full Text] [Related]
15. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children.
de Benedictis FM; del Giudice MM; Forenza N; Decimo F; de Benedictis D; Capristo A
Eur Respir J; 2006 Aug; 28(2):291-5. PubMed ID: 16641126
[TBL] [Abstract][Full Text] [Related]
16. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.
Vidal C; Fernández-Ovide E; Piñeiro J; Nuñez R; González-Quintela A
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):655-8. PubMed ID: 11428738
[TBL] [Abstract][Full Text] [Related]
17. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
Edelman JM; Turpin JA; Bronsky EA; Grossman J; Kemp JP; Ghannam AF; DeLucca PT; Gormley GJ; Pearlman DS
Ann Intern Med; 2000 Jan; 132(2):97-104. PubMed ID: 10644288
[TBL] [Abstract][Full Text] [Related]
18. No effect of montelukast on asthma-like symptoms in elite ice hockey players.
Helenius I; Lumme A; Ounap J; Obase Y; Rytilä P; Sarna S; Alaranta A; Remes V; Haahtela T
Allergy; 2004 Jan; 59(1):39-44. PubMed ID: 14674932
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
[TBL] [Abstract][Full Text] [Related]
20. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
Gaszczyk G; Latoś T; Słowikowski A; Janiak B
Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
